Company Search:
Advanced Search
Sponsored Links
Curis, Inc. Company Snapshot
Curis, Inc. operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Curis with three other companies in this sector in the United States: Enzon Pharmaceuticals, Inc. (2016 sales of $8.38 million ), Asterias Biotherapeutics Inc ($6.95 million of which 100% was Regenerative Medicine), and Editas Medicine Inc ($6.05 million of which 100% was Pharmaceutical).

Sales Analysis. Curis reported sales of $7.53 million for the year ending December of 2016. This represents a decrease of 4.5% versus 2015, when the company's sales were $7.88 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Curis, Inc.
  Stock Performance Chart for Curis, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): .70
(Figures in U.S. Dollars)
1 Week -4.8%   13 Weeks -6.6%  
4 Weeks -55.4%   52 Weeks -73.1%  
Curis, Inc. Key Data:
  Ticker: CRIS Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2016 Sales 7,527,000
(Year Ending Jan 2017).
Employees: 58
  Currency: U.S. Dollars Market Cap: 114,788,629
  Fiscal Yr Ends: December Shares Outstanding: 163,983,755
  Share Type: Common Closely Held Shares: 28,826,883
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.